Glaukos GKOS
NYSE GKOS
$190.26 +0.71 (+0.37%)
At close: Aug 20, 2026 · 12:12 PM UTC

Glaukos (GKOS) Gross Margin Growth (3y) (2017 - 2026)

Glaukos (GKOS) Gross Margin Growth (3y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Abbott Laboratories 200.51 Bn 194.91 Bn 7.27 Bn 264.00
2 Stryker 129.96 Bn 126.48 Bn 4.50 Bn 459.00
3 Medtronic 120.18 Bn 110.96 Bn 6.41 Bn 21.00
4 Boston Scientific 74.28 Bn 73.74 Bn 3.85 Bn 8.00
5 Edwards Lifesciences 52.75 Bn 48.50 Bn 1.35 Bn -316.00
6 Dexcom 34.67 Bn 32.73 Bn 830.00 Mn 73.00
7 GE HealthCare Technologies 34.23 Bn 32.12 Bn 2.18 Bn 90.00
8 Koninklijke Philips 26.46 Bn 23.14 Bn 4.55 Bn -3,577.00
9 Steris 23.30 Bn 22.82 Bn 684.20 Mn 113.00
10 Glaukos 11.19 Bn 11.08 Bn 151.59 Mn 668.00

Historic Data

Download Data
DateValue
Jun 30, 2026 668.00
Mar 31, 2026 231.00
Dec 31, 2025 -7,688.00
Sep 30, 2025 207.00
Jun 30, 2025 287.00
Mar 31, 2025 241.00
Dec 31, 2024 -412.00
Sep 30, 2024 -279.00
Jun 30, 2024 -82.00
Mar 31, 2024 81.00
Dec 31, 2023 381.00
Sep 30, 2023 394.00
Jun 30, 2023 4,366.00
Mar 31, 2023 3,433.00
Dec 31, 2022 -3.00
Sep 30, 2022 -1,049.00
Jun 30, 2022 -1,110.00
Mar 31, 2022 -1,205.00
Dec 31, 2021 -986.00
Sep 30, 2021 -688.00